Cuba’s Abdala coronavirus candidate vaccine showed “efficacy” of more than 92 percent after three doses, its maker said Monday, though it did not specify whether
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
